Matthew Lumley
Chief Executive Officer at Myosana Therapeutics, Inc.
Profile
Matthew Lumley is currently the Chief Executive Officer at Myosana Therapeutics, Inc. and a Venture Partner at Medicxi Ventures (Jersey) Ltd.
He completed his undergraduate degree at Imperial College London in 2007 and his doctorate degree at King's College London in 2015.
Matthew Lumley active positions
| Companies | Position | Start |
|---|---|---|
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Private Equity Investor | 2022-12-31 |
Myosana Therapeutics, Inc.
 Myosana Therapeutics, Inc. BiotechnologyHealth Technology Myosana Therapeutics, Inc. is a biotech company develops novel platform technology. The company was founded by Stan Froehner, Nick Whitehead and Steve Runnels and is headquartered in Seattle, WA. | Chief Executive Officer | 2021-10-31 |
Training of Matthew Lumley
| Imperial College London | Undergraduate Degree |
| King's College London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Finance |
Myosana Therapeutics, Inc.
Myosana Therapeutics, Inc. BiotechnologyHealth Technology Myosana Therapeutics, Inc. is a biotech company develops novel platform technology. The company was founded by Stan Froehner, Nick Whitehead and Steve Runnels and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Matthew Lumley
